Middle East, North Africa, Afghanistan & Pakistan (excluding high income) vs Palestine: Tuberculosis treatment success rate

Middle East, North Africa, Afghanistan & Pakistan (excluding high income)
94.0%
in 2023
Palestine
100.0%
in 2023
Middle East, North Africa, Afghanistan & Pakistan (excluding high income) rank
1st
Palestine rank
1st

Tuberculosis treatment success rate over time

  • Middle East, North Africa, Afghanistan & Pakistan (excluding high income)
  • Palestine
020406080100200020112023

How they compare

Palestine currently reports 100.0% against 94.0% in Middle East, North Africa, Afghanistan & Pakistan (excluding high income), a difference of 6.0%.

That makes Palestine's figure about 1.1 times Middle East, North Africa, Afghanistan & Pakistan (excluding high income)'s.

The two have swapped places 8 times across 19 shared years of data; in 2002 it was Palestine ahead.

Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 1st and Palestine ranks 1st of 19 groups.

Across the 3 decades both report, Middle East, North Africa, Afghanistan & Pakistan (excluding high income) averaged higher in 1 and Palestine in 2.

Head to head by decade

Decade Middle East, North Africa, Afghanistan & Pakistan (excluding high income) Palestine Difference Ahead
2000s 85.9% 94.4% 8.5% Palestine
2010s 91.0% 91.1% 0.1% Palestine
2020s 93.2% 92.5% 0.8% Middle East, North Africa, Afghanistan & Pakistan (excluding high income)

Averages of every year both report within each decade.

Frequently asked questions

Which has higher tuberculosis treatment success rate, Middle East, North Africa, Afghanistan & Pakistan (excluding high income) or Palestine?
Palestine, at 100.0% against 94.0% in Middle East, North Africa, Afghanistan & Pakistan (excluding high income) as of 2023.
What is the difference in tuberculosis treatment success rate between Middle East, North Africa, Afghanistan & Pakistan (excluding high income) and Palestine?
6.0%, with Palestine ahead.
How many years of comparable data are there for Middle East, North Africa, Afghanistan & Pakistan (excluding high income) and Palestine?
19 years are reported by both, from 2002 to 2023.
How do Middle East, North Africa, Afghanistan & Pakistan (excluding high income) and Palestine rank globally for tuberculosis treatment success rate?
Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 1st and Palestine ranks 1st of 19 groups.
Where does this data come from?
Global Tuberculosis Report, World Health Organization (WHO), published as Tuberculosis treatment success rate (% of new cases). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Middle East, North Africa, Afghanistan & Pakistan (excluding high income) vs Palestine: Tuberculosis treatment success rate. Statizoid, drawing on Global Tuberculosis Report, World Health Organization (WHO). Retrieved 18 September 2026, from https://health.statizoid.com/compare/tuberculosis-treatment-success-rate-percent-of-new-cases/middle-east-north-africa-afghanistan-and-pakistan-excluding-high-income/west-bank-and-gaza/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/tuberculosis-treatment-success-rate-percent-of-new-cases/middle-east-north-africa-afghanistan-and-pakistan-excluding-high-income/west-bank-and-gaza/">Middle East, North Africa, Afghanistan & Pakistan (excluding high income) vs Palestine: Tuberculosis treatment success rate</a> — Statizoid

About this data

Indicator
Tuberculosis treatment success rate (% of new cases)
Unit
% of new cases
Source
Global Tuberculosis Report, World Health Organization (WHO)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
222 places, 4,903 data points, 2000–2023
Last refreshed

Tuberculosis treatment success rate is the percentage of all new tuberculosis cases (or new and relapse cases for some countries) registered under a national tuberculosis control programme in a given year that successfully completed treatment, with or without bacteriological evidence of success ("cured" and "treatment completed" respectively).